TrialClinical and vaccine immunology : CVI2010

Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemic.

H M El Sahly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.